Pancreatic Cancer section

Prostate Cancer News & Features

Two-drug combination boosts survival in patients with metastatic prostate cancer

A combination therapy increased survival rates for individuals with newly diagnosed metastatic, hormone-sensitive prostate cancer.

Tell me about your prostate cancer symptoms ... Will most men talk or walk?

Tell me about your prostate cancer symptoms ... Will most men talk or walk?

Approximately 97% of men with advanced prostate cancer report being comfortable discussing their symptoms with their health care team. But the number of men who actually do so is significantly lower.

Long-term denosumab therapy safe for patients with breast, prostate cancer

Long-term denosumab therapy safe for patients with breast, prostate cancer

No new safety signals were identified for long-term denosumab therapy in patients with metastatic breast or prostate cancer and bone metastases.

ADT impacts mood of patients with prostate cancer, as perceived by partners

ADT impacts mood of patients with prostate cancer, as perceived by partners

Androgen deprivation therapy negative impacts the mood of patients with prostate cancer.

Prostate cancer not likely to be cause of death in men with low-risk disease

Prostate cancer not likely to be cause of death in men with low-risk disease

Relatively unaggressive prostate tumors are not likely to develop into metastatic disease or result in death.

Prostate Cancer Videos

Prostate Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs